Related topics

Protagonist Therapeutics: 3Q Earnings Snapshot

November 6, 2019 GMT

NEWARK, Calif. (AP) _ Protagonist Therapeutics Inc. (PTGX) on Wednesday reported a loss of $16.4 million in its third quarter.

The Newark, California-based company said it had a loss of 61 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 75 cents per share.

The biopharmaceutical company posted revenue of $4.1 million in the period.

Protagonist Therapeutics shares have risen 72% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $11.60, a rise of 33% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTGX at https://www.zacks.com/ap/PTGX